Spark Investment Management LLC Cti Biopharma Corp Transaction History

Spark Investment Management LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 08, 2018	SELL	$3.81 - $5.26 $152,400 - $210,400	-40,000 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$2.7 - $4.06 $76,410 - $114,897	28,300 Added 241.88%	40,000 $156,000
Q4 2017 Feb 12, 2018	BUY	$2.47 - $3.34 $28,899 - $39,078	11,700	11,700 $31,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.